Abstract:Muscle-eye-brain (MEB) disease is a congenital muscular dystrophy (CMD) phenotype characterized by hypotonia at birth, brain structural abnormalities and ocular malformations. To date, few MEB cases have been reported in China where clinical recognition and genetic confirmatory testing on a research basis are recent developments. Here, we report the clinical and molecular genetics of three MEB disease patients. The patients had different degrees of muscle, eye and brain symptoms, ranging from congenital hypotonia, early-onset severe myopia and mental retardation to mild weakness, independent walking and language problems. This confirmed the expanding phenotypic spectrum of MEB disease with varying degrees of hypotonia, myopia and cognitive impairment. Brain magnetic resonance imaging showed cerebellar cysts, hypoplasia and characteristic brainstem flattening and kinking. Four candidate genes (POMGnT1, FKRP, FKTN and POMT2) were screened, and six POMGnT1 mutations (four novel) were identified, including five missense and one splice site mutation. Pathogenicity of the two novel variants in one patient was confirmed by POMGnT1 enzyme activity assay, protein expression and subcellular localization of mutant POMGnT1 in HeLa cells. Transfected cells harboring this patient’s L440R mutant POMGnT1 showed POMGnT1 mislocalization to both the Golgi apparatus and endoplasmic reticulum. We have provided clinical, histological, enzymatic and genetic evidence of POMGnT1 involvement in three unrelated MEB disease patients in China. The identification of novel POMGnT1 mutations and an expanded phenotypic spectrum contributes to an improved understanding of POMGnT1 structure–function relationships, CMD pathophysiology and genotype–phenotype correlations, while underscoring the need to consider POMGnT1 in Chinese MEB disease patients.

Novel POMGnT1 Mutations Cause Muscle-Eye-brain Disease in Chinese Patients

[Clinical and Mutation Analysis of a Chinese Family with Muscle Eye Brain Disease].

Novel Copy Number Variation of POMGNT1 Associated with Muscle-Eye-brain Disease Detected by Next-Generation Sequencing

Uniparental disomy for chromosome 1 with POMGNT1 splice-site variant causes muscle-eye-brain disease

Phenotype and Genotype Study of Chinese POMT2-Related α-Dystroglycanopathy

Analysis of Phenotype, Enzyme Activity and Genotype of Chinese Patients with POMT1 Mutation.

A Gcg Expansion (gcg)(11) in Polyadenylate-Binding Protein Nuclear 1 Gene Caused Oculopharyngeal Muscular Dystrophy in A Chinese Family

Whole exome sequencing identifies a novel homozygous MECR mutation in a Chinese patient with childhood-onset dystonia and basal ganglia abnormalities, without optic atrophy

Just Expect It: Compound Heterozygous Variants of POMT1 in a Consanguineous Family—The Role of Next Generation Sequencing in Neuromuscular Disorders

Reduced proliferative activity of primary POMGnT1-null myoblasts in vitro

Clinical Exome Sequencing Identifies Novel Compound Heterozygous Mutations of the POMT2 Gene in Patients with Limb‐girdle Muscular Dystrophy

Novel Mutations in the C-terminal Region of GMPPB Causing Limb-Girdle Muscular Dystrophy Overlapping with Congenital Myasthenic Syndrome

A Novel Composition of Two Heterozygousgfm1mutations in a Chinese Child with Epilepsy and Mental Retardation

Indentification of novel MSTO1 compound heterozygous mutations in a Chinese family with recessive cerebellar atrophy and ataxia

Lysosomal degradation of GMPPB is associated with limb-girdle muscular dystrophy type 2T.

Novel Mutations in the GTPBP3 Gene for Mitochondrial Disease and Characteristics of Related Phenotypic Spectrum: The First Three Cases From China

Novel SPEG variant cause centronuclear myopathy in China.

Novel and recurrent nuclear gene variations in a cohort of Chinese progressive external ophthalmoplegia patients with multiple mtDNA deletions

Oculopharyngeal Muscular Dystrophy: Phenotypic and Genotypic Studies in a Chinese Population.

Phenotypic and Genotypic Studies in 6 Chinese Han Families with Oculopharyngeal Muscular Dystrophy

Novel Mutations in DPM3 Cause Dystroglycanopathy with Central Nervous System Involvement